Evidence map›Paper›PMID 40272396›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2025

Botulinum toxin (A)-induced bone loss is associated with increased blood velocity and reduced vascular bone porosity.

Mahmoud S Moussa, Taylor de Vet, Nadine Lebcir, Paul Zaslansky, Lorraine E Chalifour, Bettina M Willie, Svetlana V Komarova

Abstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Mahmoud S MoussaFaculty of Dental Medicine and Oral Health Science, McGill University, Montreal, QC, H3A 1G1, Canada.
Taylor de VetShriners Hospitals for Children Canada, Montreal, QC, H4A 0A9, Canada.
Nadine LebcirFaculty of Dental Medicine and Oral Health Science, McGill University, Montreal, QC, H3A 1G1, Canada.
Paul ZaslanskyDepartment for Operative, Preventive and Pediatric Dentistry, Charité-Universitätsmedizin Berlin, Berlin, 14197, Germany.
Lorraine E ChalifourLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, H3T 1E2, Canada.
Bettina M WillieFaculty of Dental Medicine and Oral Health Science, McGill University, Montreal, QC, H3A 1G1, Canada.
Svetlana V KomarovaFaculty of Dental Medicine and Oral Health Science, McGill University, Montreal, QC, H3A 1G1, Canada.

Funding

Canadian Institute for Health Research PJT-183656Canadian Space Agency #21HLSRM03Natural Sciences and Engineering Research Council #RGPIN-28825
6 · The paper itself

Abstract

Disuse-induced bone loss is a common consequence of spaceflight and prolonged bed rest. Intraosseous blood vessel volume and number are decreased in rodents after sciatic nerve resection, and femoral and tibial perfusion and blood flow to the femoral shaft and marrow are reduced after hindlimb unloading. However, it is unclear if alterations in the flow of blood contribute to botulinum toxin (BTX)-induced bone loss. The objective of this study was to assess patterns of tibial bone loss and alterations in blood flow in murine hindlimbs following BTX injection. We hypothesize that flow of blood to the affected hindlimb will diminish along with bone mass and structure. Skeletally mature C57Bl/6J female were injected with BTX (n = 15) or vehicle (n = 14). Paralysis was confirmed using digit abduction, wire hang tests, and activity analysis. In vivo microCT and ex vivo synchrotron tomography were used to assess bone mass, microstructure, (re)modeling, as well as vascular and lacunar porosity. Blood flow in the hindlimbs and cardiac structure/function was monitored by echocardiography. After 3 wk, BTX-injected tibiae had 16% lower cortical thickness and 66% lower trabecular bone volume fraction compared to baseline. MicroCT-based timelapse morphometry showed bone loss was predominantly at endocortical surfaces. Bone loss in the contralateral limb was coincident with reduced rearing capability of BTX-injected mice compared to vehicle controls. Bony vascular canal thickness and surface area were reduced, but there was no change in lacunar properties due to BTX. In vivo ultrasound demonstrated increased velocity time integral for blood flow due to BTX injection in femoral and popliteal but not in saphenous arteries. Thus, BTX led to significant bone loss in hindlimbs, while increasing blood velocity in the femoral popliteal arteries and decreasing vascular porosity. The vascular response to BTX differs from what has been observed in other hindlimb unloading models.

Indexed as

Bone and BonesBone ResorptionBotulinum Toxins, Type AAnimalsBlood Flow VelocityFemaleHindlimbMiceMice, Inbred C57BLPorosityTibiaX-Ray MicrotomographyBotulinum Toxins, Type Ablood flowbone lossbotulinum toxin Amechanical unloadingosteocyte network analysissynchrotron imagingvascular porosity

Identifiers

PMID40272396
PMCPMC12685722

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.